GSA Capital Partners’s TuHURA Biosciences HURA Stock Holding History

GSA Capital Partners’s Portfolio HURA Stock Details HURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-62,538	Closed	-$112K	–	2256
2026 Q1	$112K	Buy	+62,538	New	+$76.6K	0.01%	1555

Other funds holding HURA

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

GSA Capital Partners's HURA Position: Q2 2026 in Review

GSA Capital Partners sold out of TuHURA Biosciences (HURA) in Q2 2026, closing a stake of 62,538 shares — an estimated $112K sold.

GSA Capital Partners first reported a position in HURA in Q1 2026 and held it in 1 quarter. The position peaked at $112K in Q1 2026. 89 funds tracked by Wall St. Rank hold HURA as of Q2 2026.

GSA Capital Partners reported no remaining TuHURA Biosciences position as of Q2 2026 after selling out during the quarter.
GSA Capital Partners sold 62,538 TuHURA Biosciences shares in Q2 2026, an estimated $112K.
GSA Capital Partners first reported a position in TuHURA Biosciences in Q1 2026 and held it in 1 quarter.
GSA Capital Partners's TuHURA Biosciences position peaked at $112K in Q1 2026.
89 funds tracked by Wall St. Rank held TuHURA Biosciences as of Q2 2026.

Based on GSA Capital Partners's 13F filing for Q2 2026, filed 6 Aug 2026.